Enhancer ID: | E_01_0778 |
Species: | human |
Position : | chr20:62793633-62795633 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Prostatic cancer |
Pubmed ID: | 30076933 |
Enhancer experiment: | QPCR, Western blot, hat assay, statistical analysis |
Enhancer experiment description: | This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. |
Target gene : | MRGBP,KLK3(APS,KLK2A1,PSA,hK3) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. ;This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. ;This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. |
TF name : | TMPRSS2 |
TF experiment: | qPCR,western blot,HAT assay,???? |
TF experiment description: | This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. ;This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. ;This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. |
Enhancer function : | This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
This study showed that MRG domain binding protein (MRGBP) accelerated AR-mediated transactivation. MRGBP increased the expression of certain AR target genes, including KLK3 and TMPRSS2, and it associated with AR binding regions of these genes during androgen treatment. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
TMPRSS2 | Coregulation of Androgen receptor activity | pid | 61 |
TMPRSS2 | Regulation of Androgen receptor activity | pid | 54 |